{"id":"W2932357737","doi":"10.1111/tri.13436","title":"The therapeutic challenge of late antibody‐mediated kidney allograft rejection","year":2019,"lang":"en","type":"review","venue":"Transplant International","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"ca_institutions":"The Metabolomics Innovation Centre; University of Alberta","funders":"","keywords":"Medicine; Alloimmunity; Rituximab; Eculizumab; Antibody; Bortezomib; Kidney transplantation; Clinical trial; Immunology; Alemtuzumab; Intensive care medicine; Transplantation; Internal medicine; Multiple myeloma; Complement system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001137839,0.0006013635,0.001803279,0.001734238,0.0002050497,0.001071259,0.0006778263,0.001246208,0.002724523],"category_scores_gemma":[0.001760373,0.0001752329,0.001034013,0.001206499,0.0004398788,0.001136963,0.0005179432,0.001944947,0.000451121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005862262,"about_ca_system_score_gemma":0.001476787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009614052,"about_ca_topic_score_gemma":0.001860624,"domain_scores_codex":[0.999577,0.0001665152,0.0000729239,0.00004371478,0.0001119586,0.00002781191],"domain_scores_gemma":[0.9991073,0.0005841259,0.000133217,0.00002049371,0.0001243259,0.00003041417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001647443,0.00006407663,0.0001991915,0.07767437,0.0004972941,0.0001391996,0.00009187574,0.000319638,0.000822929,0.004600429,0.02587801,0.8895482],"study_design_scores_gemma":[0.0001309111,0.0002663073,0.002345847,0.06271738,0.001674683,0.002146083,0.0003079377,0.0003045199,0.000621043,0.006605132,0.922842,0.00003817287],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006374223,0.9992445,0.00003338671,0.0003930082,0.000089449,0.000001615612,0.000004981106,0.000001917249,0.0001674693],"genre_scores_gemma":[0.001102912,0.9981567,0.0000967727,0.0003313544,0.0001757093,0.000005533958,0.00001045408,8.47699e-7,0.0001196374],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002724523,"threshold_uncertainty_score":0.009114444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06331573931690174,"score_gpt":0.3765094538667007,"score_spread":0.3131937145497989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}